1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum : Revelations from the MANAGE-PD validation cohort
(
- Contribution to journal › Article
- 2022
-
Mark
Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease : Real-World Evidence From G7 Countries
(
- Contribution to journal › Article
- 2021
-
Mark
Close relationships in Parkinson´s disease patients with device-aided therapy
(
- Contribution to journal › Article
-
Mark
Validation and clinical value of the MANAGE-PD tool : A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications
(
- Contribution to journal › Article
- 2020
-
Mark
Everyday Occupations and Other Factors in Relation to Mental Well-Being among Persons with Advanced Parkinson’s Disease
(
- Contribution to journal › Article
- 2019
-
Mark
EuroInf 2 : Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease
2019) In Movement Disorders(
- Contribution to journal › Article
- 2018
-
Mark
Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Non-oral Continuous Drug Delivery Techniques in Parkinson's Disease : For Whom, When, and How?
(
- Contribution to journal › Scientific review
- 2015
-
Mark
EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease - Clinical practice recommendations
(
- Contribution to journal › Scientific review